Can Diabetes Drug Metformin Cut Covid-19 death risk?

1 min read
Can Diabetes Drug Metformin Cut Covid-19 death risk?

The Quint DAILY

For impactful stories you just can’t miss

By subscribing you agree to our Privacy Policy

Metformin, a generic medication for managing blood sugar levels in patients with diabetes, has been linked to significantly reduced Covid-19 death risks in women in an observational study.

It also reduces inflammation proteins like TNF-alpha that appear to make Covid-19 worse, said the research published in the journal The Lancet Healthy Longevity.

"Seeing a bigger association with protection in women over men may point towards inflammation reduction as a key way that metformin reduces risk from Covid-19," said principal investigator Carolyn Bramante, Assistant Professor at the University of Minnesota Medical School in the US.


"However, more research is needed," Bramante said.

The study is based on analysis of de-identified patient data from healthcare company UnitedHealth Group.

The team analysed about 6,000 individuals with Type-2 diabetes or obesity who were hospitalised with Covid-19 and assessed whether or not metformin use was associated with decreased mortality.

They found an association that women with diabetes or obesity, who were hospitalised for Covid-19 disease and who had filled a 90-day metformin prescription before hospitalisation, had a 21 per cent to 24 per cent reduced likelihood of mortality compared to similar women not taking the medication.

There was no significant reduction in mortality among men.

(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)

Read Latest News and Breaking News at The Quint, browse for more from fit and coronavirus

Speaking truth to power requires allies like you.
Become a Member
3 months
12 months
12 months
Check Member Benefits
Read More
Stay Updated

Subscribe To Our Daily Newsletter And Get News Delivered Straight To Your Inbox.

Join over 120,000 subscribers!
More News